GTTX
GTTX

GeneTether Therapeutics Inc.

Status
Active
Issued & Outstanding38,744,674
Reserved for Issuance17,942,855
Currency
CSE Index

About

GeneTether Therapeutics Inc.

Listing date
March 28, 2022

GeneTether Therapeutics is an innovative genetic medicines company focused on creating best-in-class gene editing therapies based on our proprietary GeneTether™ platform. Our platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs. We use a proprietary method to “tether” donor DNA templates to the genome editing complex, making the template readily available for use during the genome editing repair stage.